Prospective, Randomized Comparison of Ampicillin/Sulbactam and Cefoxitin for Diabetic Foot Infections

Vascular and Endovascular Surgery

Volumn 31, Issue 4, 1997, Pages 419-426

  Erstad, Brian L ^a   Mcintyre, Kenneth E ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOXITIN; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE; SULTAMICILLIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC FOOT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WOUND INFECTION;

EID: 1842763759     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/153857449703100403     Document Type: Article

References (22)

1. Reiber GE: Diabetic foot care. Diabetes Care. 15(suppl 1):29-31, 1992.
2. Joseph WS: Treatment of lower extremity infections in diabetics. Drugs. 42:984-996, 1991.
3. Humphrey LL, Palumbo PJ, Butters MA, et al: The contribution of noninsulin-dependent diabetes to lower-extremity amputation in the community. Arch Intern Med. 154:885-892, 1994.
4. Lipsky BA, Pecoraro RE, Larson SA, et al: Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch Intern Med. 150:790-797, 1990.
5. Hughes CE, Johnson CC, Bamberger DM, et al: Treatment and long-term follow-up of foot infections in patients with diabetes or ischemia: A randomized, prospective, double-blind comparison of cefoxitin and ceftizoxime. Clin Ther. 10(suppl A):36-49, 1987.
6. Borrero E. Rossini M.: Bacteriology of 100 consecutive diabetic foot infections and in vitro susceptibility to ampicillin/sulbactam versus cefoxitin. Angiology. 43:357-361, 1992.
7. Caputo GM, Cavanagh PR, Ulbrecht JS, et al: Assessment and management of foot disease in patients with diabetes. N Engl J Med. 331:854-860, 1994.
8. Peterson LR, Lissack LM, Canter K. et al: Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. Am J Med. 86:801-808, 1989.
9. Scher KS, Steele FJ: The septic foot in patients with diabetes. Surgery. 104:661-666, 1988.
10. Taylor LM, Porter JM: The clinical course of diabetics who require emergent foot surgery because of infection or ischemia. J Vasc Surg. 6:454-459, 1987.
11. LoGerfor FW, Gibbons GW, Pomposelli FB, et al: Trends in the care of the diabetic foot: Expanded role of arterial reconstruction. Arch Surg. 127:617-621, 1992.
12. Criado E. De Stefano AA, Keagy BA, et al: The course of severe foot infection in patients with diabetes. Surg Gynecol Obstet. 175:135-140, 1992.
13. McIntyre KE, Bailey SA, Malone JM, et al: Guillotine amputation in the treatment of nonsalvageable lower-extremity infections. Arch Surg. 119:450-453, 1984.
14. Fierer J. Daniel D. Davis C.: The fetid foot: Lower-extremity infections in patients with diabetes mellitus. Rev Infect Dis. 1:210-217, 1979.
15. LeFrock JL, Blais F. Schell RF, et al: Cefoxitin in the treatment of diabetic patients with lower extremity infections. Infect Surg. 2:361-374, 1983.
16. LeFrock JL, Schell RF, Carr BB, et al: Cefoxitin therapy in aerobic, anaerobic, and mixed aerobic-anaerobic infections. Drug Intell Clin Pharm. 16:306-312, 1982.
17. Schurman DJ, Burton DS, Kajiyama G.: Cefoxitin antibiotic concentration in bone and synovial fluid. Clin Orthop Rel Res. 168:64-68, 1982.
18. Seabrook GR, Edmiston CE, Schmitt DD, et al: Comparison of serum and tissue antibiotic levels in diabetes-related foot infections. Surgery. 10:671-677, 1991.
19. Louie TJ, Bartlett JG, Tally FP, et al: Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med. 85:461-463, 1976.
20. Wheat LJ, Allen SD, Henry M. et al:, Diabetic foot infections: Bacteriologic analysis. Arch Intern Med. 146:1935-1940, 1986.
21. Sharp CS, Bessman AN, Wagner FW, et al: Microbiology of superficial and deep tissues in infected diabetic gangrene. Surg Gynecol Obstet. 149:217-219, 1979.
22. Sapico FL, Witte JL, Canawati HN, et al: The infected foot of the diabetic patient: Quantitative microbiology and analysis of clinical features. Rev Infect Dis. 6(suppl 1):S171-S176, 1984.